ILMN
Illumina Inc
NASDAQ: ILMN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$120.37
-5.16% today
Updated 2026-04-29
Market cap
$18.29B
P/E ratio
22.09
P/S ratio
4.21x
EPS (TTM)
$5.45
Dividend yield
—
52W range
$74 – $156
Volume
1.6M
Illumina Inc (ILMN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-14.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.4%
Last 4 reports
Positive reaction rate
0%
0 of 4 quarters
Largest single-day move
-11.3%
2025-07-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-28 | $0.00 | -100.0% | $128.52 | $120.37 | -6.3% |
| 2026-02-05 | $1.35 | +10.7% | $134.19 | $119.72 | -10.8% |
| 2025-11-03 | $1.34 | +14.5% | $123.54 | $116.86 | -5.4% |
| 2025-07-31 | $1.19 | +17.8% | $106.66 | $94.66 | -11.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $1.07 | $0.00 | -100.0% | — | — |
| 2025-12-31 | $1.22 | $1.35 | +10.7% | $1.16B | +5.0% |
| 2025-09-30 | $1.17 | $1.34 | +14.5% | $1.08B | +0.3% |
| 2025-06-30 | $1.01 | $1.19 | +17.8% | $1.06B | -4.8% |
| 2025-03-31 | $0.94 | $0.97 | +3.2% | $1.04B | -3.3% |
| 2024-12-31 | $0.92 | $0.86 | -6.5% | $1.10B | -1.6% |
| 2024-09-30 | $0.88 | $1.14 | +29.5% | $1.08B | -3.5% |
| 2024-06-30 | $0.90 | $0.36 | -60.0% | $1.11B | — |
| 2024-03-31 | $0.04 | $0.09 | +125.0% | $1.08B | — |
| 2023-12-31 | $0.02 | $0.14 | +600.0% | $1.12B | — |
| 2023-09-30 | $0.12 | $0.33 | +175.0% | $1.12B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $5.12 | $4.6B | +6.5% | 24 | high |
| 2027 (E) | $6.15 | $5.0B | +8.4% | 24 | high |
| 2028 (E) | $7.25 | $5.5B | +9.5% | 24 | medium |
| 2029 (E) | $8.65 | $6.1B | +10.4% | 24 | medium |
| 2030 (E) | $10.35 | $6.8B | +11.5% | 24 | medium |
Frequently asked questions
Has Illumina Inc beaten earnings estimates?
Illumina Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -14.2% over the last 4 quarters.
How does ILMN stock react to earnings?
ILMN stock has moved an average of -8.4% in the trading day following earnings over its last 4 reports, with positive reactions in 0% of those quarters.
What is the expected EPS for ILMN in 2026?
Analysts expect Illumina Inc to report EPS of $5.12 for fiscal year 2026, on revenue of $4.6B, based on estimates from 24 analysts.